دورية أكاديمية
أعرض في EDS

High compliance to ERAS protocol does not improve overall survival in patients treated for resectable advanced gastric cancer.

التفاصيل البيبلوغرافية
العنوان: High compliance to ERAS protocol does not improve overall survival in patients treated for resectable advanced gastric cancer.
المؤلفون: Rubinkiewicz M; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland., Pisarska M; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland., Zarzycki P; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland., Truszkiewicz K; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland., Witowski J; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland., Su M; Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland., Kupis R; Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland., Gajdosz A; Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland., Pędziwiatr M; 2 Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland.
المصدر: Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques [Wideochir Inne Tech Maloinwazyjne] 2020 Dec; Vol. 15 (4), pp. 553-559. Date of Electronic Publication: 2020 Feb 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Termedia Country of Publication: Poland NLM ID: 101283175 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1895-4588 (Print) Linking ISSN: 18954588 NLM ISO Abbreviation: Wideochir Inne Tech Maloinwazyjne Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Poznań : Termedia, 2006-
مستخلص: Introduction: The ERAS (Enhanced Recovery after Surgery) protocol revolutionized perioperative care for gastrointestinal surgical procedures. However, little is known about the association between adherence to the ERAS protocol in gastric cancer surgery and the oncological outcome.
Aim: To explore the relation between adherence to the ERAS protocol and the oncological outcome in gastric cancer patients.
Material and Methods: We performed a retrospective analysis of a prospectively collected database of patients treated for gastric cancer between 2013 and 2016. All patients were treated perioperatively with a 14-item ERAS protocol. Every patient underwent regular follow-up every 3 months for 3 years after surgery. 80% compliance to the ERAS protocol was the goal during perioperative care. Based on the level of compliance, patients were divided into group 1 and group 2 (compliance of ≥ 80% and < 80%, respectively).
Results: Compliance to the ERAS protocol was not a risk factor for diminished overall survival - probability of 3-year survival was 63% in group 1 and 56% in group 2 (p = 0.75). The proportional Cox model revealed that only stage III gastric cancer was a risk factor of poor prognosis in patients operated on for gastric cancer (HR = 7.89, 95% CI: 2.96-20.89; p = 0.0001).
Conclusions: High adherence to the ERAS protocol did not improve overall survival in our 3-year observation. Only the stage of the disease, according to the AJCC classification, was identified as a risk factor for poor prognosis.
Competing Interests: The authors declare no conflict of interest.
(Copyright: © 2020 Fundacja Videochirurgii.)
References: Wideochir Inne Tech Maloinwazyjne. 2017;12(1):7-12. (PMID: 28446926)
World J Gastroenterol. 2015 Jun 28;21(24):7343-8. (PMID: 26139980)
Eur J Surg Oncol. 2017 Aug;43(8):1433-1439. (PMID: 28528188)
Wideochir Inne Tech Maloinwazyjne. 2018 Sep;13(3):326-332. (PMID: 30302145)
Wideochir Inne Tech Maloinwazyjne. 2018 Dec;13(4):442-447. (PMID: 30524613)
J Thorac Dis. 2017 Jul;9(Suppl 8):S781-S784. (PMID: 28815074)
Obes Surg. 2019 Feb;29(2):492-498. (PMID: 30443718)
J Thorac Dis. 2019 Apr;11(Suppl 5):S685-S691. (PMID: 31080645)
World J Surg Oncol. 2018 Jan 26;16(1):17. (PMID: 29373978)
World J Surg. 2016 Jul;40(7):1741-7. (PMID: 26913728)
Ann Surg. 2018 Jun;267(6):992-997. (PMID: 29303803)
Wideochir Inne Tech Maloinwazyjne. 2014 Mar;9(1):13-7. (PMID: 24729804)
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. (PMID: 27664260)
Br J Surg. 2014 Sep;101(10):1209-29. (PMID: 25047143)
Clin Nutr. 2012 Dec;31(6):801-16. (PMID: 23062720)
World J Surg. 2019 Mar;43(3):659-695. (PMID: 30426190)
Dis Colon Rectum. 2017 Aug;60(8):761-784. (PMID: 28682962)
Adv Med Sci. 2016 Sep;61(2):306-310. (PMID: 27152766)
Ann Surg. 2018 Jun;267(6):998-999. (PMID: 29462010)
Surg Endosc. 2020 May;34(5):2067-2075. (PMID: 31385073)
Int J Surg. 2015 Sep;21:75-81. (PMID: 26231994)
Wideochir Inne Tech Maloinwazyjne. 2018 Mar;13(1):88-94. (PMID: 29643964)
Wideochir Inne Tech Maloinwazyjne. 2015 Apr;10(1):30-6. (PMID: 25960790)
J Thorac Dis. 2019 Apr;11(Suppl 5):S845-S850. (PMID: 31080668)
World J Surg. 2017 Apr;41(4):1040-1046. (PMID: 27882418)
Med Sci Monit. 2017 Mar 23;23:1421-1427. (PMID: 28331173)
World J Surg Oncol. 2019 Mar 18;17(1):52. (PMID: 30885211)
World J Surg. 2019 Oct;43(10):2552-2560. (PMID: 31286185)
فهرسة مساهمة: Keywords: adherence; enhanced recovery after surgery; gastrectomy; gastric cancer; laparoscopy
تواريخ الأحداث: Date Created: 20201209 Latest Revision: 20220418
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7687667
DOI: 10.5114/wiitm.2020.92833
PMID: 33294069
قاعدة البيانات: MEDLINE
الوصف
تدمد:1895-4588
DOI:10.5114/wiitm.2020.92833